A study evaluating Platelet Reactivity in continuous-flow Left Ventricular Assist Device (CF-LVAD) Implantation patients treated with P2Y12 inhibitors: Clopidogrel (CLO), Prasugrel (PRA), or Ticagrelor

Trial Profile

A study evaluating Platelet Reactivity in continuous-flow Left Ventricular Assist Device (CF-LVAD) Implantation patients treated with P2Y12 inhibitors: Clopidogrel (CLO), Prasugrel (PRA), or Ticagrelor

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Apr 2017

At a glance

  • Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Ticagrelor (Primary)
  • Indications Thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top